Código QR (código de barras bidimensional)

Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials

Abstract Patients with multiple myeloma (MM) often use cardiovascular medications due to their increased risk of cardiovascular diseases. This study investigated the associations of baseline use of these drugs with survival and adverse events in MM patients initiating daratumumab, lenalidomide, or b...

Fuld beskrivelse

Na minha lista:
Principais autores: Ahmad Y. Abuhelwa, Sara A Almansour, Humaid O. Al-Shamsi, Ziad Abuhelwa, Mohammad A. Y. Alqudah, Yasser Bustanji, Mohammad H Semreen, Karem H Alzoubi, Natansh D Modi, Ross A McKinnon, Michael J. Sorich, Ashley M Hopkins
Format: Artigo
Sprog:Inglês
Udgivet: Nature Portfolio 2026-02-01
Serier:Scientific Reports
Fag:
Multiple myeloma
Cardiovascular drugs
Treatment outcomes
Overall survival
Progression-free survival
Adverse events
Online adgang:https://doi.org/10.1038/s41598-026-37464-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker